Skip to main content
51°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
First Wave Biopharma Inc
(NQ:
FWBI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about First Wave Biopharma Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
5 Analysts Have This to Say About First Wave BioPharma
April 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 14, 2023
Via
Benzinga
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 05, 2023
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite...
Via
Benzinga
Why Is First Wave BioPharma (FWBI) Stock Up 30% Today?
January 25, 2023
FWBI stock traders are in a buying mood today as First Wave BioPharma adds to its body of medical patent applications.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 05, 2023
Via
Benzinga
Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
April 05, 2023
Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday.
Via
Benzinga
HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors
March 13, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
March 14, 2023
Tuesday's morning session saw 84 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 09, 2023
Via
Benzinga
First Wave BioPharma, Inc. (NASDAQ: FWBI) Featured in Coverage of the 35th Annual Roth Conference
February 17, 2023
Via
Investor Brand Network
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 25, 2023
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 25, 2023
Via
Benzinga
US Stocks Open Lower; Dow Dips 250 Points
January 25, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.74% to 33,484.47 while the NASDAQ fell...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 25, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 19, 2023
We're starting off Thursday with an overview of the biggest pre-market stock movers traders will want to keep an eye on!
Via
InvestorPlace
Why First Wave BioPharma Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
January 17, 2023
Gainers Celyad Oncology SA (NASDAQ: CYAD) rose 221.7% to $2.57 in pre-market trading after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 17, 2023
We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
January 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 09, 2023
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 27, 2022
Via
Benzinga
First Wave BioPharma Files IND For Enhanced Formulation Of Adrulipase; Topline Results Expected 1H/2023 ($FWBI)
December 01, 2022
Via
AB Newswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 22, 2022
It's time to start the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday morning!
Via
InvestorPlace
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
November 22, 2022
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...
Via
Benzinga
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket
November 22, 2022
Gainers ObsEva SA (NASDAQ: OBSV) shares rose 71.9% to $0.2848 in pre-market trading after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.